Molecular neuroimaging in rodents: Assessing receptor expression and function

European Journal of Neuroscience

Volumn 30, Issue 10, 2009, Pages 1860-1869

  Mueggler, Thomas ^a   Baltes, Christof ^a   Rudin, Markus ^a,b  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Molecular imaging; Neuroimaging; Receptor distribution; Rodents; Signal transduction

Indexed keywords

2 BETA CARBOMETHOXY 3 BETA (4 FLUORO PHENY)TROPANE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 2 METHYL 6 (3 METHOXYPHENYL ETHYNYL PYRIDINE; 2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; ABP 688 C11; AMPHETAMINE; BICUCULLINE; CARBON 11; ETICLOPRIDE; FLUORINE 18; GADOTERIC ACID; PHENCYCLIDINE; QUINPIROLE; RACLOPRIDE C 11; RADIOPHARMACEUTICAL AGENT; RIVASTIGMINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN FUNCTION; CENTRAL NERVOUS SYSTEM; CHEMICAL REACTION; CHEMICAL STRUCTURE; COMPUTER ASSISTED TOMOGRAPHY; DEGENERATIVE DISEASE; DRUG HALF LIFE; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG TARGETING; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUNTINGTON CHOREA; IN VIVO STUDY; MOLECULAR IMAGING; NEUROBIOLOGY; NEUROIMAGING; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SCIENTIST; STRUCTURE ACTIVITY RELATION; TREATMENT RESPONSE;

ANIMALS; BRAIN; BRAIN MAPPING; GENE EXPRESSION; IMAGE PROCESSING, COMPUTER-ASSISTED; LIGANDS; MAGNETIC RESONANCE IMAGING; MICE; MOLECULAR IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTORS, CELL SURFACE; RODENTIA; SIGNAL TRANSDUCTION;

EID: 70449697975     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2009.06987.x     Document Type: Review

References (60)

1. Agdeppa, E.D., Kepe, V., Liu, J., Small, G.W., Huang, S.C., Petric, A., Satyamurthy, N. Barrio, J.R. (2003) 2-Dialkylamino-6-acylmalononitrile substituted naphthalenes (DDNP analogs): novel diagnostic and therapeutic tools in Alzheimer's disease. Mol. Imaging Biol., 5, 404 417.
2. Ametamey, S.M., Kessler, L.J., Honer, M., Wyss, M.T., Buck, A., Hintermann, S., Auberson, Y.P., Gasparini, F. Schubiger, P.A. (2006) Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5. J. Nucl. Med., 47, 698 705.
3. Bacskai, B.J., Hickey, G.A., Skoch, J., Kajdasz, S.T., Wang, Y., Huang, G.F., Mathis, C.A., Klunk, W.E. Hyman, B.T. (2003) Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice. Proc. Natl Acad. Sci. USA, 100, 12462 12467.
4. Berger, A.B., Witte, M.D., Denault, J.B., Sadaghiani, A.M., Sexton, K.M., Salvesen, G.S. Bogyo, M. (2006) Identification of early intermediates of caspase activation using selective inhibitors and activity-based probes. Mol. Cell, 23, 509 521.
5. Chen, Y.C.I., Galpern, W.R., Brownell, A.L., Matthews, R.T., Bogdanov, M., Isacson, O., Keltner, J.R., Beal, M.F., Rosen, B.R. Jenkins, B.G. (1997) Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis and behavioural data. Magn. Reson. Med., 38, 389 398.
6. Chen, Y.C.I., Choi, J.K., Andersen, S.L., Rosen, B.R. Jenkins, B.G. (2005) Mapping dopamine D2/D3 receptor function using pharmacological magnetic resonance imaging. Psychopharmacology (Berl.), 180, 705 715.
7. 2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch. Gen. Psychiatry, 45, 71 76.
8. Fields, S. Song, O. (1989) A novel genetic system to detect protein-protein interactions. Nature, 340, 245 246.
9. Foerster, T. (1948) Intermolecular energy migration and fluorescence. Ann. Phys. Leipzig, 2, 55 75.
10. Gambhir, S.S. (2004) Quantitative assay development for PET. In Phelps, M.E. (ed. PET - Molecular Imaging and Its Biological Applications. Springer-Verlag, New York, pp. 125 216.
11. Gozzi, A., Large, C.H., Schwarz, A., Bertani, S., Crestan, V. Bifone, A. (2008a) Differential effects of antipsychotic and glutamatergic agents on the phMRI response to phencyclidine. Neuropsychopharmacology, 33, 1690 1703.
12. Gozzi, A., Schwarz, A., Crestan, V. Bifone, A. (2008b) Pharmacological manganese-enhanced MRI (MEMRI) without osmotic breakdown of the blood brain barrier. Proc. Intl. Soc. Mag. Reson. Med., 16, 2314.
13. Hamill, T.G., Krause, S., Ryan, C., Bonnefous, C., Govek, S., Seiders, T.J., Cosford, N.D., Roppe, J., Kamenecka, T., Patel, S., Gibson, R.E., Sanabria, S., Riffel, K., Eng, W., King, C., Yang, X., Green, M.D., O'Malley, S.S., Hargreaves, R. Burns, H.D. (2005) Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers. Synapse, 56, 205 216.
14. Harada, H., Kizaka-Kondoh, S., Itasaka, S., Shibuya, K., Morinibu, A., Shinomiya, K. Hiraoka, M. (2007) The combination of hypoxia-response enhancers and an oxygen-dependent proteolytic motif enables real-time imaging of absolute HIF-1 activity in tumor xenografts. Biochem. Biophys. Res. Commun., 360, 791 796.
15. Hintersteiner, M., Frey, P., Gremlich, H.U., Kinzy, W., Kneuer, R., Neumann, U., Rudin, M., Staufenbiel, M. Wiederhold, K.H. (2005) In vivo detection of amyloid deposits by near-infrared fluorescence imaging using a novel oxazine derivative as contrast agent. Nat. Biotechnol., 23, 577 583.
16. Hyde, D., DeKleine, R., MacLaurin, S.A., Miller, E., Brooks, D.H., Krucker, T. Ntziachristos, V. (2009) Hybrid FMT-CT method for in vivo imaging of amyloid-β plaques in a murine model forAlzheimer's disease. Neuroimage, 44, 1304 1311.
17. Hynynen, K. (2008) Ultrasound for drug and gene delivery to the brain. Adv. Drug Deliv. Rev., 60, 1209 1217.
18. Ishimaru, A. (1997) Wave Propagation and Scattering in Random Media. IEEE Press, New York.
19. Judenhofer, M.S., Wehrl, H.F., Newport, D.F., Catana, C., Siegel, S.B., Becker, M., Thielscher, A., Kneilling, M., Lichy, M.P., Eichner, M., Klingel, K., Reischl, G., Widmaier, S., Röcken, M., Nutt, R.E., Machulla, H.J., Uludag, K., Cherry, S.R., Claussen, C.D. Pichler, B.J. (2008) Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat. Med., 14, 459 465.
20. Klunk, W.E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D.P., Bergström, M., Savitcheva, I., Huang, G.F., Estrada, S., Ausén, B., Debnath, M.L., Barletta, J., Price, J.C., Sandell, J., Lopresti, B.J., Wall, A., Koivisto, P., Antoni, G., Mathis, C.A. Långström, B. (2004) Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann. Neurol., 55, 306 319. (Pubitemid 38269583)
21. Kudo, Y. (2006) Development of amyloid imaging PET probes for an early diagnosis of Alzheimer's disease. Minim. Invasive Ther. Allied Technol., 15, 209 213.
22. Kuhn, H. (1948) Qunatum mechanical theory of light absorption of organic dyes and similar compounds. J. Chem. Phys., 17, 1198 1212.
23. Lehmann, S., Stiehl, D.P., Honer, M., Dominietto, M., Keist, R., Kotevic, I., Wollenick, K., Ametamey, S., Wenger, R.H. Rudin, M. (2009) Longitudinal and multimodal in vivo imaging of tumor hypoxia and its downstream molecular events. Proc. Natl Acad. Sci. USA, 106, 14004 14009.
24. Lloyd, B., Sczcerba, D., Rudin, M. Szekely, G. (2008) A computational framework for modelling solid tumour growth. Philos. Transact. A Math. Phys. Eng. Sci., 366, 3301 3318.
25. Logothetis, N.K. (2008) What we can do and what we cannot do with fMRI. Nature, 453, 869 878.
26. Luker, G.D., Sharma, V., Pica, C.M., Dahlheimer, J.L., Li, W., Ochesky, J., Ryan, C.E., Piwnica-Worms, H. Piwnica-Worms, D.L. (2002) Noninvasive imaging of protein-protein interactions in living animals. Proc. Natl Acad. Sci. USA, 99, 6961 6966.
27. Michnick, S.W. (2001) Exploring protein interactions by interaction-induced folding of proteins from complementary peptide fragments. Curr. Opin. Struct. Biol., 11, 472 477.
28. Mueggler, T., Baumann, D., Rausch, M. Rudin, M. (2001) Bicuculline-induced brain activation in mice detected by functional magnetic resonance imaging. Magn. Reson. Med., 46, 292 298.
29. Ntziachristos, V., Ripoll, J., Wang, L.V. Weissleder, R. (2005) Looking and listening to light: the evolution of whole-body photonic imaging. Nat. Biotechnol., 23, 313 320.
30. Ogawa, S., Lee, T.M., Kay, A.R. Tank, D.W. (1990) Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc. Natl Acad. Sci. USA, 87, 9868 9872.
31. Patel, S., Ndubizu, O., Hamill, T., Chaudhary, A., Burns, H.D., Hargreaves, R. Gibson, R.E. (2005) Screening cascade and development of potential Positron Emission Tomography radiotracers for mGluR5: in vitro and in vivo characterization. Mol. Imaging Biol., 7, 314 323.
32. Paulmurugan, R. Gambhir, S.S. (2003) Monitoring protein-protein interactions using split synthetic Renilla luciferase protein-fragment-assisted complementation. Anal. Chem., 75, 1584 1589.
33. Paulmurugan, R., Umezawa, Y. Gambhir, S.S. (2002) Noninvasive imaging of protein-protein interactions in living subjects by using reporter protein complementation and reconstitution strategies. Proc. Natl Acad. Sci. USA, 99, 15608 15613.
34. Paulmurugan, R., Massoud, T., Huang, J. Gambhir, S.S. (2004) Molecular imaging of drug-modulated protein-protein interactions in living subjects. Cancer Res., 64, 2113 2119. (Pubitemid 38339461)
35. Phelps, M.E. (2004) PET: Molecular Imaging and its Biological Applications. Springer, New York.
36. Rausch, M., Gentsch, C., Enz, A., Baumann, D. Rudin, M. (2005) Characterization of CNS drugs by mapping changes in regional CBV in the rat: a study paradigm allowing for automated comparison of three-dimensional data obtained multiple imaging sessions. NMR Biomed., 18, 260 268.
37. Ray, P., Pimenta, H., Paulmurugan, R., Berger, F., Phelps, M.E., Iyer, M. Gambhir, S.S. (2002) Noninvasive quantitative imaging of protein-protein interactions in living subjects. Proc. Natl Acad. Sci. USA, 99, 3105 3110.
38. Reese, T., Bjelke, B., Porszasz, R., Baumann, D., Bochelen, D., Sauter, A. Rudin, M. (2000) Regional brain activation by bicuculline visualized by functional magnetic resonance imaging: time-resolved assessment of bicuculline-induced changes in local cerebral blood volume using an intravascular contrast agent. NMR Biomed., 13, 43 49.
39. Reese, T., Bochelen, D., Baumann, D., Rausch, M., Sauter, A. Rudin, M. (2002) Impaired functionality of reperfused brain tissue following short transient focal ischemia in rats. Magn. Reson. Imaging, 20, 447 454.
40. Rudin, M. (2005) Molecular imaging - Basic Principles and Applications in Biomedical Research. Imperial College Press, London.
41. Rudin, M. (2008) Noninvasive imaging of receptor function: signal transduction pathways and physiological readouts. Curr. Opin. Drug Discov. Devel., 11, 606 615.
42. Rudin, M. Weissleder, R. (2003) Molecular imaging in drug discovery and development. Nat. Rev. Drug Discov, 3, 123 131.
43. Safran, M., Kim, W.Y., O'Connell, F., Flippin, L., Günzler, V., Horner, J.W., Depinho, R.A. Kaelin, W.G. Jr. (2006) Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: assessment of an oral agent that stimulates erythropoietin production. Proc. Natl Acad. Sci. USA, 103, 105 110.
44. Scanley, B.E., Kennan, R.P. Gore, J.C. (2001) Changes in rat cerebral blood volume due to modulation of the 5-HT(1A) receptor measured with susceptibility enhanced contrast MRI. Brain Res., 913, 149 155.
45. Schwarz, A.J., Zocchi, A., Reese, T., Gozzi, A., Garzotti, M., Varnier, G., Curcuruto, O., Sartori, I., Girlanda, E., Biscaro, B., Crestan, V., Bertani, S., Heidbreder, C. Bifone, A. (2004) Concurrent pharmacological MRI and in situ microdialysis of cocaine reveal a complex relationship between the central hemodynamic response and local dopamine concentration. Neuroimage, 23, 296 304.
46. Schwarz, A.J., Gozzi, A., Reese, T. Bifone, A. (2007) In vivo mapping of functional connectivity in neurotransmitter systems using pharmacological MRI. Neuroimage, 34, 1627 1636.
47. Shaner, N.C., Steinbach, P.A. Tsien, R.Y. (2005) A guide to choosing fluorescent proteins. Nat. Methods, 2, 905 909.
48. Shoghi-Jadid, K., Small, G.W., Agdeppa, E.D., Kepe, V., Ercoli, L.M., Siddarth, P., Read, S., Satyamurthy, N., Petric, A., Huang, S.C. Barrio, J.R. (2002) Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Am. J. Geriatr. Psychiatry, 10, 24 35.
49. Sigurdson, C.J., Nilsson, K.P., Hornemann, S., Manco, G., Polymenidou, M., Schwarz, P., Leclerc, M., Hammarström, P., Wüthrich, K. Aguzzi, A. (2007) Prion strain discrimination using luminescent conjugated polymers. Nat. Methods, 4, 1023 1030.
50. Silverman, D.H.S. Melega, W.P. (2004) Molecular imaging of biological processes with PET: evaluating biological bases of cerebral function. In Phelps, M.E. (ed. PET - Molecular Imaging and Its Biological Applications. Springer-Verlag, New York, pp. 509 583.
51. Slifstein, M. Laruelle, M. (2001) Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers. Nucl. Med. Biol., 28, 595 608.
52. Soto, C. Estrada, L.D. (2008) Protein misfolding and neurodegeneration. Arch. Neurol., 65, 184 189.
53. Tauscher, J. Kapur, S. (2001) Choosing the right dose of antipsychotics in schizophrenia. CNS Drugs, 15, 671 677.
54. Tung, C.H., Mahmood, U., Bredow, S. Weissleder, R. (2000) In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res., 60, 4953 4958.
55. Verhoeff, N.P., Wilson, A.A., Takeshita, S., Trop, L., Hussey, D., Singh, K., Kung, H.F., Kung, M.P. Houle, S. (2004) In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET. Am. J. Geriatr. Psychiatry, 12, 584 595.
56. Watson, A., Wu, X. Bruchez, M. (2003) Lighting up cells with qunatum dots. BioTechniques, 34, 296 303.
57. Wise, R.G. Tracey, I. (2006) The role of fMRI in drug discovery. J. Magn. Reson. Imaging, 23, 862 876.
58. Yoffe, A.D. (2001) Semiconductor quantum dots and related systems: electronic, optical, luminescence and related properties of low dimensional systems. Adv. Phys., 50, 1 208.
59. Yu, M., Tueckmantel, W., Wang, X., Zhu, A., Kozikowski, A.P. Brownell, A.L. (2005a) Methoxyphenylethynyl, methoxypyridylethynyl and phenylethynyl derivatives of pyridine: synthesis, radiolabeling and evaluation of new PET ligands for metabotropic glutamate subtype 5 receptors. Nucl. Med. Biol., 32, 631 640.
60. Yu, X., Wadghiri, Y.Z., Sanes, D.H. Turnbull, D.H. (2005b) In vivo auditory brain mapping in mice with Mn-enhanced MRI. Nat. Neurosci., 8, 961 968.